BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20204730)

  • 1. A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension.
    Rehman J; Archer SL
    Adv Exp Med Biol; 2010; 661():171-85. PubMed ID: 20204730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.
    Bonnet S; Michelakis ED; Porter CJ; Andrade-Navarro MA; Thébaud B; Bonnet S; Haromy A; Harry G; Moudgil R; McMurtry MS; Weir EK; Archer SL
    Circulation; 2006 Jun; 113(22):2630-41. PubMed ID: 16735674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.
    Archer SL; Marsboom G; Kim GH; Zhang HJ; Toth PT; Svensson EC; Dyck JR; Gomberg-Maitland M; Thébaud B; Husain AN; Cipriani N; Rehman J
    Circulation; 2010 Jun; 121(24):2661-71. PubMed ID: 20529999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.
    Archer SL; Gomberg-Maitland M; Maitland ML; Rich S; Garcia JG; Weir EK
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H570-8. PubMed ID: 18083891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications.
    Archer SL
    Adv Exp Med Biol; 2016; 903():29-53. PubMed ID: 27343087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
    Boucherat O; Peterlini T; Bourgeois A; Nadeau V; Breuils-Bonnet S; Boilet-Molez S; Potus F; Meloche J; Chabot S; Lambert C; Tremblay E; Chae YC; Altieri DC; Sutendra G; Michelakis ED; Paulin R; Provencher S; Bonnet S
    Am J Respir Crit Care Med; 2018 Jul; 198(1):90-103. PubMed ID: 29394093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dynamics in pulmonary arterial hypertension.
    Ryan J; Dasgupta A; Huston J; Chen KH; Archer SL
    J Mol Med (Berl); 2015 Mar; 93(3):229-42. PubMed ID: 25672499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic theory of pulmonary arterial hypertension.
    Paulin R; Michelakis ED
    Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
    Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
    Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for DNA damage signaling in pulmonary arterial hypertension.
    Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
    Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.
    Ryan JJ; Archer SL
    Circulation; 2015 May; 131(19):1691-702. PubMed ID: 25964279
    [No Abstract]   [Full Text] [Related]  

  • 13. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
    Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
    J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
    Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mitochondria in pulmonary vascular remodeling.
    Dromparis P; Sutendra G; Michelakis ED
    J Mol Med (Berl); 2010 Oct; 88(10):1003-10. PubMed ID: 20734021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fawn-Hooded Rat; an animal model of development of pulmonary hypertension].
    Muramatsu M
    Nihon Rinsho; 2001 Jun; 59(6):1070-5. PubMed ID: 11411115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics.
    Dasgupta A; Wu D; Tian L; Xiong PY; Dunham-Snary KJ; Chen KH; Alizadeh E; Motamed M; Potus F; Hindmarch CCT; Archer SL
    Compr Physiol; 2020 Mar; 10(2):713-765. PubMed ID: 32163206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
    Fan YF; Zhang R; Jiang X; Wen L; Wu DC; Liu D; Yuan P; Wang YL; Jing ZC
    Cardiovasc Res; 2013 Aug; 99(3):395-403. PubMed ID: 23650288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?
    Courboulin A; Ranchoux B; Cohen-Kaminsky S; Perros F; Bonnet S
    Curr Opin Oncol; 2016 Jan; 28(1):72-82. PubMed ID: 26569423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.